BACKGROUND: Survivors of pediatric brain tumors (BT) and acute lymphoblastic leukemia (ALL) are at risk for neurocognitive late effects related to executive function. PROCEDURE: Survivors of BT (48) and ALL (50) completed neurocognitive assessment. Executive function was compared to estimated IQ and population norms by diagnostic group. RESULTS: Both BT and ALL demonstrated relative executive function weaknesses. As a group, BT survivors demonstrated weaker executive functioning than expected for age. Those BT survivors with deficits exhibited a profile suggestive of global executive dysfunction, while affected ALL survivors tended to demonstrate specific rapid naming deficits. CONCLUSION: Findings suggest that pediatric BT and ALL survivors may exhibit different profiles of executive function late effects, which may necessitate distinct intervention plans.
BACKGROUND: Survivors of pediatric brain tumors (BT) and acute lymphoblastic leukemia (ALL) are at risk for neurocognitive late effects related to executive function. PROCEDURE: Survivors of BT (48) and ALL (50) completed neurocognitive assessment. Executive function was compared to estimated IQ and population norms by diagnostic group. RESULTS: Both BT and ALL demonstrated relative executive function weaknesses. As a group, BT survivors demonstrated weaker executive functioning than expected for age. Those BT survivors with deficits exhibited a profile suggestive of global executive dysfunction, while affected ALL survivors tended to demonstrate specific rapid naming deficits. CONCLUSION: Findings suggest that pediatric BT and ALL survivors may exhibit different profiles of executive function late effects, which may necessitate distinct intervention plans.
Entities:
Keywords:
Brain tumor; Executive function; Late effects; Leukemia; Pediatric
Authors: Laura K Campbell; Mary Scaduto; William Sharp; Lynette Dufton; Deborah Van Slyke; James A Whitlock; Bruce Compas Journal: Pediatr Blood Cancer Date: 2007-07 Impact factor: 3.167
Authors: Catherine C Peterson; Courtney E Johnson; Lisa Y Ramirez; Samantha Huestis; Ahna L H Pai; Heath A Demaree; Dennis Drotar Journal: Pediatr Blood Cancer Date: 2008-07 Impact factor: 3.167
Authors: R J Packer; J Goldwein; H S Nicholson; L G Vezina; J C Allen; M D Ris; K Muraszko; L B Rorke; W M Wara; B H Cohen; J M Boyett Journal: J Clin Oncol Date: 1999-07 Impact factor: 44.544
Authors: Lisa S Kahalley; Heather M Conklin; Vida L Tyc; Stephanie J Wilson; Pamela S Hinds; Shengjie Wu; Xiaoping Xiong; Melissa M Hudson Journal: Pediatr Blood Cancer Date: 2011-02-18 Impact factor: 3.167
Authors: Kevin R Krull; Pim Brouwers; Neelam Jain; Linna Zhang; Lisa Bomgaars; ZoAnn Dreyer; Donald Mahoney; Sarah Bottomley; M Fatih Okcu Journal: J Pediatr Date: 2007-10-24 Impact factor: 4.406
Authors: Tara M Brinkman; Chenghong Li; Kathryn Vannatta; Jordan G Marchak; Jin-Shei Lai; Pinki K Prasad; Cara Kimberg; Stefanie Vuotto; Chongzhi Di; Deokumar Srivastava; Leslie L Robison; Gregory T Armstrong; Kevin R Krull Journal: J Clin Oncol Date: 2016-07-18 Impact factor: 44.544
Authors: Tanya N Antonini; M Douglas Ris; David R Grosshans; Anita Mahajan; M Fatih Okcu; Murali Chintagumpala; Arnold Paulino; Amanda E Child; Jessica Orobio; Heather H Stancel; Lisa S Kahalley Journal: Radiother Oncol Date: 2017-06-24 Impact factor: 6.280
Authors: Meghan Hegarty-Craver; Kristin H Gilchrist; Cathi B Propper; Gregory F Lewis; Samuel J DeFilipp; Jennifer L Coffman; Michael T Willoughby Journal: Behav Res Methods Date: 2018-10
Authors: Avani C Modi; Matthew Schmidt; Aimee W Smith; Luke Turnier; Noah Glaser; Shari L Wade Journal: Epilepsy Behav Date: 2017-06-07 Impact factor: 2.937
Authors: Kelli L Netson; Jason M Ashford; Traci Skinner; Lynne Carty; Shengjie Wu; Thomas E Merchant; Heather M Conklin Journal: J Neurooncol Date: 2016-03-31 Impact factor: 4.130
Authors: Kristina K Hardy; Victoria W Willard; Anthony Gioia; Christina Sharkey; Karin S Walsh Journal: Neuro Oncol Date: 2018-04-09 Impact factor: 12.300
Authors: Stephanie B Dixon; Kari L Bjornard; Nicole M Alberts; Gregory T Armstrong; Tara M Brinkman; Wassim Chemaitilly; Matthew J Ehrhardt; Israel Fernandez-Pineda; Lisa M Force; Todd M Gibson; Daniel M Green; Carrie R Howell; Sue C Kaste; Anne C Kirchhoff; James L Klosky; Kevin R Krull; John T Lucas; Daniel A Mulrooney; Kirsten K Ness; Carmen L Wilson; Yutaka Yasui; Leslie L Robison; Melissa M Hudson Journal: CA Cancer J Clin Date: 2018-01-29 Impact factor: 508.702